Bone metastases are associated with worse prognosis in patients affected by metastatic colorectal cancer treated with doublet or triplet chemotherapy plus bevacizumab: a subanalysis of the tribe and tribe2 trials

HIGHLIGHTS

• who: E. Dellu2019Aquila from the Medical, IRCCS Regina Elena National Cancer Institute, RomeMedical, IRCCS Regina Elena National Cancer Institute, Rome have published the article: Bone metastases are associated with worse prognosis in patients affected by metastatic colorectal cancer treated with doublet or triplet chemotherapy plus bevacizumab: a subanalysis of the TRIBE and TRIBE2u00a0trials, in the Journal: (JOURNAL) of 31/07/2014
• what: Because of the retrospective nature of this analysis, no data were collected regarding the use of antiresorptive agents or other bonedirected therapies.
• how: Drawing from these considerations the authors carried out . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.